WPATH argues its gender-care guidelines are merely one view in a contested medical debate

The World Professional Association for Transgender Health submitted a filing in the FTC’s fraud case, asserting that the ten claims the agency labels deceptive are merely opinions on a subject with ongoing medical and scientific debate, and therefore shielded by the First Amendment. The FTC’s complaint relies on internal WPATH communications obtained through a subpoena in Alabama, alleging that the group suppressed unfavorable systematic-review findings while promoting its SOC-8 guideline.

WPATH points out that the SOC-8 document itself states a systematic review of adolescent outcomes is “not possible.” The association’s standards have been adopted by Medicaid in Oregon and major insurers such as Kaiser, Aetna, Cigna and UnitedHealthcare for coverage decisions. Past statements from officials like Assistant Secretary for Health Rachel Levine described WPATH’s guidelines as the prevailing evidence-based standard, a claim WPATH now reframes as one perspective among many. Critics note the organization’s history of portraying puberty blockers, hormones and surgeries as medically necessary and of pressuring dissenting clinicians.